![]() This may be because they used a different chemotherapy routine (FAMTEX: fluorouracil, doxorubicin, methotrexate) before surgery. The researchers here found no significant benefit to pairing chemotherapy with surgery. It compared chemotherapy before surgery to surgery alone. This study happened before the MAGIC trial.“Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial1.” European journal of surgical oncology 30.6 (2004): 643-649. They found that patients receiving radiation and chemotherapy were less likely to have cancer relapse and survived longer. This was compared to patients only having surgery. This study looked at radiation combined with chemotherapy after gastric cancer surgery.“Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.” Journal of Clinical Oncology 30.19 (2012): 2327. So, the MAGIC trial showed the benefits of perioperative chemotherapy for patients with resectable gastric cancer. The average progression-free survival was around 18 months in Group A. Group A patients lived longer without cancer than Group B patients did over at least 5 years. Also, fewer lymph nodes had cancer in Group A patients than in Group B. This means the medicine was helpful in treating the cancer. Researchers found that tumors from Group A patients were smaller and less advanced. ![]() The removed tumors and lymph nodes were examined. Results: There were no significant differences in post-operative complications, deaths within 30 days of surgery, adverse effects and the length of hospital stay between Groups A and B. The lymph nodes were examined in the lab to determine if they had cancer cells. The surgeon decided how many lymph nodes should be removed based on the patient’s condition. In gastric cancer, lymph nodes near the stomach can also become diseased and are taken out (known as a lymphadenectomy ). The doctor chose the type of surgery depending on where the tumor was located. This could be a radical total gastrectomy or a radical distal gastrectomy. Surgery: All patients had a type of gastrectomy surgery. The researchers checked up on the patients for the next 5 years. Group B patients had surgery 6 weeks after the start of the trial. It was given intravenously every day of the chemotherapy cycle.
0 Comments
Leave a Reply. |